152 related articles for article (PubMed ID: 8731835)
1. [Anti-hepatitis C virus screening to prevent hepatitis C virus infection in blood donors].
Sun Y; Zhao Y; Liu X
Zhonghua Nei Ke Za Zhi; 1995 Oct; 34(10):696-9. PubMed ID: 8731835
[TBL] [Abstract][Full Text] [Related]
2. [Hepatitis C virus infection among the plasmapheresis donors].
Wang S; Ding H; Zhang H
Zhonghua Liu Xing Bing Xue Za Zhi; 1994 Apr; 15(2):71-3. PubMed ID: 7522967
[TBL] [Abstract][Full Text] [Related]
3. [Epidemiological and serological study on hepatitis C virus infection in plasmapheresis donors].
Sun Y
Zhonghua Liu Xing Bing Xue Za Zhi; 1991 Dec; 12(6):327-30. PubMed ID: 1667379
[TBL] [Abstract][Full Text] [Related]
4. [Seroepidemiological study on hepatitis C virus infection among blood donors from various regions in China].
Tang S
Zhonghua Liu Xing Bing Xue Za Zhi; 1993 Oct; 14(5):271-4. PubMed ID: 7511060
[TBL] [Abstract][Full Text] [Related]
5. [Hepatitis C virus in plasmapheresis donors].
Padrón GJ; Rodríguez Z; Rivera L; Arús E; Beltrán J; Roca J; Pantaleón B
Sangre (Barc); 1995 Jun; 40(3):187-90. PubMed ID: 7570270
[TBL] [Abstract][Full Text] [Related]
6. [Epidemiological study of hepatitis C virus (HCV) infection in plasmapheresis and blood donors].
Jin ZL; Chen SQ; Shi ZY
Zhonghua Liu Xing Bing Xue Za Zhi; 1995 Aug; 16(4):234-6. PubMed ID: 7585906
[TBL] [Abstract][Full Text] [Related]
7. The persistence of hepatitis C virus transmission risk in China despite serologic screening of blood donations.
Wang J; Liu J; Huang Y; Wright DJ; Li J; Zhou Z; He W; Yang T; Yao F; Zhu X; Wen G; Bi X; Tiemuer MH; Wen X; Huang M; Cao R; Yun Z; Lü Y; Ma H; Guo N; Yu Q; Ness P; Shan H;
Transfusion; 2013 Oct; 53(10 Pt 2):2489-97. PubMed ID: 23781978
[TBL] [Abstract][Full Text] [Related]
8. [Studies on HDV and HCV infection in plasma donors with positive HBsAg].
Wang SP; Ding H; Zhao OK
Zhonghua Yu Fang Yi Xue Za Zhi; 1994 Jul; 28(4):223-4. PubMed ID: 7531135
[TBL] [Abstract][Full Text] [Related]
9. [Prevalence of hepatitis C virus markers in Polish blood donors in 1994-2003].
Seyfried H; Brojer E; Grabarczyk P; Rosińska M; Gronowska A; Letowska M;
Przegl Epidemiol; 2005; 59(4):807-14. PubMed ID: 16729421
[TBL] [Abstract][Full Text] [Related]
10. [Evaluation of screening and complementary tests for anti-HCV antibodies].
Głoskowska-Moraczewska Z; Kacperska E; Seyfried H
Acta Haematol Pol; 1993; 24(3):273-80. PubMed ID: 7504386
[TBL] [Abstract][Full Text] [Related]
11. Hepatitis C virus : prevalence in Lebanese blood donors and brief overview of the disease.
Araj GF; Kfoury-Baz EE; Barada KA; Nassif RE; Alami SY
J Med Liban; 1995; 43(1):11-6. PubMed ID: 8676356
[TBL] [Abstract][Full Text] [Related]
12. Prevalence and risk factors of hepatitis C infection after cardiac surgery in childhood before and after blood donor screening.
Vogt M; Mühlbauer F; Braun SL; Lang T; Busch R; Lange R; Frösner G; Hess J
Infection; 2004 Jun; 32(3):134-7. PubMed ID: 15188071
[TBL] [Abstract][Full Text] [Related]
13. Significance of the signal-to-cutoff ratios of anti-hepatitis C virus enzyme immunoassays in screening of Chinese blood donors.
Ren FR; Lv QS; Zhuang H; Li JJ; Gong XY; Gao GJ; Liu CL; Wang JX; Yao FZ; Zheng YR; Zhu FM; Tiemuer MH; Bai XH; Shan H
Transfusion; 2005 Nov; 45(11):1816-22. PubMed ID: 16271110
[TBL] [Abstract][Full Text] [Related]
14. Prevalence and trends of hepatitis C virus among blood donors in Antananarivo, from 2003 to 2009.
Randriamanantany ZA; Rajaonatahina DH; Razafimanantsoa FÉ; Rasamindrakotroka MT; Andriamahenina R; Rasoarilalaomanarivo FB; Hanitriniala SP; Herisoa FR; Rakoto-Alson OA; Rasamindrakotroka A
Transfus Clin Biol; 2012 Apr; 19(2):52-6. PubMed ID: 22410302
[TBL] [Abstract][Full Text] [Related]
15. The hepatitis C virus genotype and subtype frequency in hepatitis C virus RNA-positive, hepatitis C virus antibody-negative blood donors identified in the nucleic acid test screening program in Poland.
Brojer E; Gronowska A; Medyńska J; Grabarczyk P; Mikulska M; Letowska M; Kryczka W; Gietka A
Transfusion; 2004 Dec; 44(12):1706-10. PubMed ID: 15584984
[TBL] [Abstract][Full Text] [Related]
16. [Examination of a Berlin blood donation branch for antibodies to hepatitis C virus with the anti-HCV test and for circulating HCV-RNA using polymerase chain reaction].
Zimmermann R; König V; Bauditz J; Zeiler T; Zingsem J; Heuft HG; Hopf U; Huhn D; Eckstein R
Beitr Infusionsther; 1992; 30():38-41. PubMed ID: 1284740
[TBL] [Abstract][Full Text] [Related]
17. Prevalence of hepatitis C virus antibodies and genotypes in asymptomatic, first-time blood donors in Namibia.
Vardas E; Sitas F; Seidel K; Casteling A; Sim J
Bull World Health Organ; 1999; 77(12):965-72. PubMed ID: 10680243
[TBL] [Abstract][Full Text] [Related]
18. Hepatitis C virus infection in volunteer blood donors in Taiwan. Evaluation by hepatitis C antibody assays and the polymerase chain reaction.
Wang JT; Wang TH; Sheu JC; Tsai SJ; Hsieh YS; Lin DT; Wang CY; Chen DS
Arch Pathol Lab Med; 1993 Feb; 117(2):152-6. PubMed ID: 8381269
[TBL] [Abstract][Full Text] [Related]
19. Detection of antibody to hepatitis C virus E2 recombinant antigen among samples indeterminate for anti-HCV after wide serological testing and correlation with viremia. The Spanish Study Group for Blood Donors at Risk of Transmission of HCV.
León P; López JA; Elola C; Domingo CJ; Echevarria JM
Vox Sang; 1996; 70(4):213-6. PubMed ID: 9123926
[TBL] [Abstract][Full Text] [Related]
20. Evaluation of a pooling method for routine anti-HCV screening of blood donors to lower the cost burden on blood banks in countries under development.
García Z; Taylor L; Ruano A; Pavón L; Ayerdis E; Luftig RB; Visoná KA
J Med Virol; 1996 Jul; 49(3):218-22. PubMed ID: 8818968
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
